RADVAN, Martin, Petr SVOBODA, Jana RADVANOVA, Josef STUMAR and Peter SCHEER. Brain Natriuretic Peptide in Decompensation of Liver Cirrhosis in Non-cardiac Patients. Hepato-gastroenterology. 2009, vol. 56, No 89, p. 181-185. ISSN 0172-6390.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Brain Natriuretic Peptide in Decompensation of Liver Cirrhosis in Non-cardiac Patients
Name in Czech BNP u pacientů s dekompenzovanou jaterní cirhózou bez kardiologického onemocnění
Authors RADVAN, Martin, Petr SVOBODA, Jana RADVANOVA, Josef STUMAR and Peter SCHEER.
Edition Hepato-gastroenterology, 2009, 0172-6390.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Greece
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 0.669
Organization unit Faculty of Medicine
UT WoS 000265203100038
Keywords (in Czech) mozkový natriuretický hormon; cirhóza; ascites; kardiomyopatie
Keywords in English Brain natriuretic; peptides; cirrhosis; ascites; cardiomyopathy
Tags International impact
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 20/4/2012 11:02.
Abstract
Brain natriuretic peptide is recently widely used as a diagnostic and prognostic marker of heart failure. Plasma levels of this peptide are elevated in other, non-cardiac conditions as well, among others in liver cirrhosis, especially presenting with fluid retention and, - ascites. Methods: Circulating levels of BNP was determined in 25 non-cardiac patients, 20 men, 5 women admitted at our medicine department from March 2006 to September 2007 with decompensate ascitic liver cirrhosis. Severity of disease was measured by Child and MELD (Model of End Stage of Liver Disease) score. Results: Plasma BNP was increased in our patients (range 21-1078pg/ml) and significantly correlated with the severity of liver failure assigned as Child's classification (r=0.51; p=0.009) and MELD score (r=0.56; p=0.003) as well as with the glomerular filtration rate (r=-0.62; p=0.0009). Four patients with initial BNP >600 ng/L died, while all 21 patients with BNP <600 ng/L survived (p=0.0019). Conclusion: B-type natriuretic peptide in plasma correlated significantly with the severity of liver disease in cirrhotic patients. High plasma BNP seems to be a good negative prognostic factor of the death in cirrhosis.
Abstract (in Czech)
B typ BNP v plazmě byl statisticky významně závislý na závažnosti onemocnění u pacientů s jaterní cirhózou. Vysoká hladina BNP zřejmě bude dobrý prognostický faktor pro úmrtí u cirhotiků
PrintDisplayed: 22/7/2024 20:26